Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seraph Group is a global early-stage venture capital and angel investment firm, not an operational biotech, pharmaceutical, or healthcare company. It invests across a range of sectors, including but not limited to life sciences, by funding high-growth startups via structured funds and direct investment syndicates. The firm has invested in over 150 startups across 135+ cities, with a portion of its portfolio in biotech and healthcare, but does not develop drugs, devices, or clinical programs itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seraph Group.